Canaan Partners Xi LLC Tyra Biosciences, Inc. Transaction History
Canaan Partners Xi LLC
- $59.7 Million
- Q4 2024
A detailed history of Canaan Partners Xi LLC transactions in Tyra Biosciences, Inc. stock. As of the latest transaction made, Canaan Partners Xi LLC holds 4,179,857 shares of TYRA stock, worth $67.6 Million. This represents 97.27% of its overall portfolio holdings.
Number of Shares
4,179,857
Previous 4,409,991
5.22%
Holding current value
$67.6 Million
Previous $104 Million
43.96%
% of portfolio
97.27%
Previous 97.89%
Shares
2 transactions
Others Institutions Holding TYRA
# of Institutions
99Shares Held
43.2MCall Options Held
353KPut Options Held
1.1K-
Ra Capital Management, L.P. Boston, MA10.4MShares$169 Million3.41% of portfolio
-
Boxer Capital, LLC San Diego, CA6.45MShares$104 Million8.05% of portfolio
-
Bvf Inc San Francisco, CA4.66MShares$75.4 Million3.48% of portfolio
-
Nextech Invest Ag4.06MShares$65.6 Million15.55% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA1.99MShares$32.2 Million6.07% of portfolio
About Tyra Biosciences, Inc.
- Ticker TYRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,973,600
- Market Cap $679M
- Description
- Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...